Blood thinner duration tool for first blood clot
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests a decision aid to help patients who have had a first unprovoked or mildly provoked blood clot decide how long to continue taking blood thinners. It may help you feel more confident in your treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had a first blood clot in your leg or lungs that was unprovoked or only mildly provoked.
- You have taken blood thinners for at least 3 months and still take them now.
- You were diagnosed within the last 12 months.
- You can understand English or French.
- You have not had a previous visit to decide about long-term blood thinner use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
This study looks at when it is safest to start blood thinners to prevent blood clots (deep vein thrombosis) after a type of bleeding stroke called hypertensive intracerebral hemorrhage. Researchers want to find the best time to start this prevention treatment.
This study helps you and your doctor decide together whether to continue blood thinners after a first unexpected blood clot. You join after 3 to 6 months of treatment to discuss your options.
This Phase 3 trial compares the best “blood thinner” approach for people who have a new clot in the leg (DVT) or lung (PE) and who already take antiplatelet medicines for heart or blood-vessel prevention. It aims to find an antithrombotic plan that lowers clot risk while managing bleeding risk.
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
This registry collects information from people who had a clot (venous thromboembolism) and start blood thinners soon after diagnosis. It may help doctors better understand treatment patterns and outcomes after early blood-thinner use.
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.